Researchers have developed a new oral drug that boosts metabolic activity in muscle rather than altering appetite like GLP-1 ...
With Medicare Open Enrollment ending next week, the Centers for Medicare & Medicaid Services (CMS) has announced that last ...
Dietitian Live has mapped a repeatable subconscious-to-physiology pathway showing that when belief shifts, the body heals. The company uncovered a consistent, client-partnered process for rewiring ...
Alkem Laboratories has got the go-ahead from the Subject Expert Committee (SEC) functioning under the Central Drugs Standard ...
Diabetology recently received formal recognition as a distinct physician specialty, which represents a milestone for ...
Resmetirom effectively resolves MASH and improves fibrosis, independent of GLP-1 or SGLT2 inhibitor use, in patients with T2DM. Achieving ≥5% weight loss enhances resmetirom's effects on MASH ...
New research finds that popular type 2 diabetes drug metformin can impact the brain. Here’s why that matters and what it means for treatment, per doctors.
Nerve damage is one of the most common and burdensome complications of diabetes. Millions of patients worldwide suffer from ...
Nerve damage is one of the most common and burdensome complications of diabetes. Millions of patients worldwide suffer from ...
Although there is one GLP-1 medication, Rybelsus, currently given as a daily pill, it has so far only been prescribed as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results